260 related articles for article (PubMed ID: 30006714)
21. Fibronectin aggregation in multiple sclerosis lesions impairs remyelination.
Stoffels JM; de Jonge JC; Stancic M; Nomden A; van Strien ME; Ma D; Sisková Z; Maier O; Ffrench-Constant C; Franklin RJ; Hoekstra D; Zhao C; Baron W
Brain; 2013 Jan; 136(Pt 1):116-31. PubMed ID: 23365094
[TBL] [Abstract][Full Text] [Related]
22. Gain of Olig2 function in oligodendrocyte progenitors promotes remyelination.
Wegener A; Deboux C; Bachelin C; Frah M; Kerninon C; Seilhean D; Weider M; Wegner M; Nait-Oumesmar B
Brain; 2015 Jan; 138(Pt 1):120-35. PubMed ID: 25564492
[TBL] [Abstract][Full Text] [Related]
23. The expression of myelin protein mRNAs during remyelination of lysolecithin-induced demyelination.
Woodruff RH; Franklin RJ
Neuropathol Appl Neurobiol; 1999 Jun; 25(3):226-35. PubMed ID: 10417664
[TBL] [Abstract][Full Text] [Related]
24. Apoptosis of Oligodendrocytes during Early Development Delays Myelination and Impairs Subsequent Responses to Demyelination.
Caprariello AV; Batt CE; Zippe I; Romito-DiGiacomo RR; Karl M; Miller RH
J Neurosci; 2015 Oct; 35(41):14031-41. PubMed ID: 26468203
[TBL] [Abstract][Full Text] [Related]
25. Tracking the evolution of CNS remyelinating lesion in mice with neutral red dye.
Baydyuk M; Cha DS; Hu J; Yamazaki R; Miller EM; Smith VN; Kelly KA; Huang JK
Proc Natl Acad Sci U S A; 2019 Jul; 116(28):14290-14299. PubMed ID: 31235582
[TBL] [Abstract][Full Text] [Related]
26. Acceleration in the rate of CNS remyelination in lysolecithin-induced demyelination.
Pavelko KD; van Engelen BG; Rodriguez M
J Neurosci; 1998 Apr; 18(7):2498-505. PubMed ID: 9502810
[TBL] [Abstract][Full Text] [Related]
27. Differential local tissue permissiveness influences the final fate of GPR17-expressing oligodendrocyte precursors in two distinct models of demyelination.
Coppolino GT; Marangon D; Negri C; Menichetti G; Fumagalli M; Gelosa P; Dimou L; Furlan R; Lecca D; Abbracchio MP
Glia; 2018 May; 66(5):1118-1130. PubMed ID: 29424466
[TBL] [Abstract][Full Text] [Related]
28. Dorsally-derived oligodendrocytes in the spinal cord contribute to axonal myelination during development and remyelination following focal demyelination.
Zhu Q; Whittemore SR; Devries WH; Zhao X; Kuypers NJ; Qiu M
Glia; 2011 Nov; 59(11):1612-21. PubMed ID: 21710609
[TBL] [Abstract][Full Text] [Related]
29. Efficient Remyelination Requires DNA Methylation.
Moyon S; Ma D; Huynh JL; Coutts DJC; Zhao C; Casaccia P; Franklin RJM
eNeuro; 2017; 4(2):. PubMed ID: 28451635
[TBL] [Abstract][Full Text] [Related]
30. Remyelination induced by a DNA aptamer in a mouse model of multiple sclerosis.
Nastasijevic B; Wright BR; Smestad J; Warrington AE; Rodriguez M; Maher LJ
PLoS One; 2012; 7(6):e39595. PubMed ID: 22761835
[TBL] [Abstract][Full Text] [Related]
31. The Notch signaling pathway: its role in focal CNS demyelination and apotransferrin-induced remyelination.
Aparicio E; Mathieu P; Pereira Luppi M; Almeira Gubiani MF; Adamo AM
J Neurochem; 2013 Dec; 127(6):819-36. PubMed ID: 24032544
[TBL] [Abstract][Full Text] [Related]
32. Migration and remyelination by oligodendrocyte progenitor cells transplanted adjacent to focal areas of spinal cord inflammation.
Wang Y; Piao JH; Larsen EC; Kondo Y; Duncan ID
J Neurosci Res; 2011 Nov; 89(11):1737-46. PubMed ID: 21793039
[TBL] [Abstract][Full Text] [Related]
33. Identification of post-mitotic oligodendrocytes incapable of remyelination within the demyelinated adult spinal cord.
Keirstead HS; Blakemore WF
J Neuropathol Exp Neurol; 1997 Nov; 56(11):1191-201. PubMed ID: 9370229
[TBL] [Abstract][Full Text] [Related]
34. Suppression of remyelination in the CNS by X-irradiation.
Blakemore WF; Patterson RC
Acta Neuropathol; 1978 May; 42(2):105-13. PubMed ID: 654883
[TBL] [Abstract][Full Text] [Related]
35. Multiple Sclerosis: Basic and Clinical.
Buzzard K; Chan WH; Kilpatrick T; Murray S
Adv Neurobiol; 2017; 15():211-252. PubMed ID: 28674983
[TBL] [Abstract][Full Text] [Related]
36. rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination.
Mullin AP; Cui C; Wang Y; Wang J; Troy E; Caggiano AO; Parry TJ; Colburn RW; Pavlopoulos E
Neurobiol Dis; 2017 Sep; 105():142-155. PubMed ID: 28576706
[TBL] [Abstract][Full Text] [Related]
37. Matrix metalloproteinase-9 facilitates remyelination in part by processing the inhibitory NG2 proteoglycan.
Larsen PH; Wells JE; Stallcup WB; Opdenakker G; Yong VW
J Neurosci; 2003 Dec; 23(35):11127-35. PubMed ID: 14657171
[TBL] [Abstract][Full Text] [Related]
38. Observations on remyelination in the rabbit spinal cord following demyelination induced by lysolecithin.
Blakemore WF
Neuropathol Appl Neurobiol; 1978; 4(1):47-59. PubMed ID: 683458
[TBL] [Abstract][Full Text] [Related]
39. Failure of remyelination in areas of demyelination produced in the spinal cord of old rats.
Gilson J; Blakemore WF
Neuropathol Appl Neurobiol; 1993 Apr; 19(2):173-81. PubMed ID: 8316337
[TBL] [Abstract][Full Text] [Related]
40. Myelin regulatory factor drives remyelination in multiple sclerosis.
Duncan GJ; Plemel JR; Assinck P; Manesh SB; Muir FGW; Hirata R; Berson M; Liu J; Wegner M; Emery B; Moore GRW; Tetzlaff W
Acta Neuropathol; 2017 Sep; 134(3):403-422. PubMed ID: 28631093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
